Join Now

Category Archives: BioUtah News

Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

By Press Release | Published November 6, 2025

The target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty (PTA) through 24 months

| Tagged | Comments Off on Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

By Press Release | Published November 6, 2025

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

| Tagged | Comments Off on Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

By Press Release | Published November 6, 2025

Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx’s existing and future AI initiatives

| Tagged , | Comments Off on Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Health Insurance Costs 2026: Steep Increases Ahead for Employers, Including Life Sciences

By Press Release | Published November 5, 2025

Health insurance costs are projected to rise sharply in 2026

Also posted in Guests Posts, HR | | Tagged | Comments Off on Health Insurance Costs 2026: Steep Increases Ahead for Employers, Including Life Sciences

Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics

By Press Release | Published November 5, 2025

Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics

| Comments Off on Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics

Owlet® Strengthens Market Leadership as Dream Sight™ Becomes the First Baby Monitor Awarded the SGS Cybersecurity Mark

By Press Release | Published October 30, 2025

Earning the first-ever SGS Cybersecurity Mark in the baby monitor category, Owlet reinforces its leadership in safety, security, privacy, and innovation.

| Tagged | Comments Off on Owlet® Strengthens Market Leadership as Dream Sight™ Becomes the First Baby Monitor Awarded the SGS Cybersecurity Mark

Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East

By Press Release | Published October 30, 2025

The new Saudi-based CoMira Diagnostics joint venture will be engaged in manufacturing and distribution of the Company’s upcoming Co-Dx™ PCR platform and other Co-Dx IP across KSA and 18 other MENA countries

| Tagged | Comments Off on Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East

EDWARDS SAPIEN 3 TAVR DELIVERS PROVEN LONG-TERM BENEFITS AND VALVE PERFORMANCE, NEW DATA PRESENTED AT TCT 2025

By Press Release | Published October 30, 2025

SAPIEN 3, which showed superiority at 1 year, also demonstrates compelling outcomes equivalent to surgery at seven years

| Tagged | Comments Off on EDWARDS SAPIEN 3 TAVR DELIVERS PROVEN LONG-TERM BENEFITS AND VALVE PERFORMANCE, NEW DATA PRESENTED AT TCT 2025

SUCCESSFUL PATIENT OUTCOMES DEMONSTRATED WITH EDWARDS’ SAPIEN M3 AND EVOQUE SYSTEMS, NEW DATA PRESENTED AT TCT 2025

By Press Release | Published October 30, 2025

ENCIRCLE mitral trial achieves primary and secondary endpoints.

| Tagged | Comments Off on SUCCESSFUL PATIENT OUTCOMES DEMONSTRATED WITH EDWARDS’ SAPIEN M3 AND EVOQUE SYSTEMS, NEW DATA PRESENTED AT TCT 2025

DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research

By Press Release | Published October 30, 2025

DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research

| Tagged | Comments Off on DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research

BioUtah Life Sciences Delegation Showcases Utah Innovation in Australia

By admin | Published October 23, 2025

As part of Governor Spencer Cox’s Australia Trade Mission from October 19–25, BioUtah led a focused Life Sciences Track highlighting Utah’s growing global leadership in biotechnology, medtech, diagnostics, and health innovation. The delegation met with prominent Australian partners, investors, and regulators to explore opportunities for collaboration and market expansion. Companies participating in the trade mission […]

| Comments Off on BioUtah Life Sciences Delegation Showcases Utah Innovation in Australia

Seek Labs Expands Global Disease Atlas to Include Hemorrhagic Fever Viruses

By admin | Published October 23, 2025

    Salt Lake City, Utah – October 21, 2025 Salt Lake City-based biotech firm Seek Labs announced today that it has expanded its Global Disease Atlas™ to include several of the world’s deadliest hemorrhagic fever viruses (HFVs) — namely, Ebola virus, Marburg virus, Lassa virus, Hantavirus, Crimean‑Congo hemorrhagic fever virus (CCHFV), and Rift Valley fever virus (RVFV). In July, the company announced that it […]

| Comments Off on Seek Labs Expands Global Disease Atlas to Include Hemorrhagic Fever Viruses

A Special Thanks To Our Elite Members